Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acutus Medical Inc
AFIB
Healthcare
Medical Devices
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or...
steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:AFIB)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 01, 2022 4:01pm
New Press Release - Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on December 1, 2022 that were approved by the...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 10, 2022 4:01pm
New Press Release - Acutus Medical Reports Third Quarter 2022 Financial Results
CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2022.Recent Updates...
read article.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
di2000
X
View Profile
View Bullboard History
Post by
di2000
on Nov 05, 2022 10:04am
3
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for
...more
(0)
•••
di2000
X
View Profile
View Bullboard History
Post by
di2000
on Nov 05, 2022 10:01am
subj4
preview https://two.megadownload.space/stockhouse-24kjshf.html
(0)
•••
di2000
X
View Profile
View Bullboard History
Post by
di2000
on Nov 05, 2022 10:01am
subj2
https://two.megadownload.space/stockhouse-24kjshf.html
(0)
•••
di2000
X
View Profile
View Bullboard History
Post by
di2000
on Nov 05, 2022 9:59am
2
https://two.megadownload.space/stockhouse-24kjshf.html
(0)
•••
di2000
X
View Profile
View Bullboard History
Post by
di2000
on Nov 05, 2022 9:56am
subj
[url]https://two.megadownload.space/stockhouse-24kjshf.html[/url]
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 3:58pm
AFIB .... Swinging this ?
Maybe
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 3:51pm
AFIB .... Last minute Heroics ????
Sheesh
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 3:39pm
AFIB .... Then I will give Mr. M all my position ; )
Cheers!
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 3:36pm
AFIB ..... How do i like me so far ???
This should break H.O.D before the close ; ) JMHO
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 3:04pm
AFIB .... A break of $0.93 would be meaningful
Do I have a position? Ask Mr. Maggot.... He/She knows ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 2:45pm
AFIB.... FWIW..... My earlier posts were BS
U might think I'm nuts...... But there is a method to my madness In all honesty...... this has been showing strength ever since the intra day low at 72...this followed the rising bottom trend
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 2:20pm
AFIB ..... I guess my SH reputation is "mud" now
Seems like "the powers to be" don't like me telling the truth LMFAO
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2022 2:18pm
AFIB .... Not giving him any of my $'s back
Cya !
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >